The role of COVID‐19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19970 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Gaurav N Pathak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey, USA. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Pemphigus, COVID-19 Vaccines, Recurrence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey, USA.
- Department of Computer Science, Rutgers University School of Arts and Sciences, New Brunswick, New Jersey, USA.
- Department of Dermatology, Weill Cornell School of Medicine, New York, New York, USA.
- Department of Dermatology, Rao Dermatology, Atlantic Highlands, New Jersey, USA.
ORCID-Profile: Gaurav N Pathak
Zitieren
APA
Pathak, G. N., Pathak, A. N., & Rao, B. (2024). The role of COVID‐19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19970
Vancouver
Pathak GN, Pathak AN, Rao B. The role of COVID‐19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19970
BibTeX
@article{Pathak2024,
author = {Pathak, Gaurav N and Pathak, Anurag N and Rao, Babar},
title = {The role of COVID‐19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19970}
}
EUVIMED